Abstract:Abstract Oral squamous cell carcinoma (OSCC) is a prevalent form of cancer that develops in the oral cavity, globally recognized as the eighth most commonly diagnosed cancer. Despite the application of standard surgical techniques or concurrent chemoradiotherapy, the prognosis for OSCC patients remains unsatisfactory. Initially, cisplatin, the primary and most frequently used chemotherapy agent for treating OSCC, demonstrates effectiveness in therapy. Nonetheless, chemoresistance frequently arises, leading to treatment failure, and this is intricately associated with the activation of hypoxia-inducible factor 1α (HIF-1α) signaling. Recent research has brought to light heightened levels of HIF-1α-mediated vascular endothelial growth factor (VEGF) and BCL-2 in OSCC tumor sites, which play crucial roles in regulating angiogenesis and anti-apoptotic processes within cancer cells. Additionally, interventions aimed at targeting anti-apoptotic molecules or augmenting the expression of pro-apoptotic molecules may represent promising strategies to overcome chemoresistance in OSCC. Therefore, HIF-1α/VEGF/BCL-2 axis could be considered a potential target for the development of chemopreventive and chemotherapeutic strategies for OSCC. Lenvatinib is a targeted multi-kinase inhibitor that can inhibit tumor growth and angiogenesis by blocking the activation of vascular endothelial growth factor receptor (VEGFR) 1-3, fibroblast growth factor receptor (FGFR) 1-4, platelet-derived growth factor receptor (PDGFR) α, as well as the proto-oncogenes RET and KIT. However, whether lenvatinib may sensitizes OSCC to cisplatin remains unclear. In our study, we used the MTT assay to prove the cytotoxicity of OSCC cells (SAS and MOC1 cells) was induced by cisplatin and lenvatinib. We employed flow cytometry to verify that the combination of lenvatinib and cisplatin can indeed trigger both extrinsic and intrinsic apoptotic pathways in OSCC cells. Furthermore, our demonstration revealed that the induction of apoptosis pathways by the combination of lenvatinib and cisplatin is associated with mitochondrial-dependent apoptosis and death receptor-dependent apoptosis. Then, transwell invasion and migration assay results proved the inhibition effect of lenvatinib combined with cisplatin in SAS and MOC1 cells. Furthermore, we indicated that the combination of lenvatinib and cisplatin can effectively inhibit angiogenesis and anti-apoptotic mechanisms mediated by the HIF-1α/VEGF/BCL-2 axis in OSCC cells. In summary, our results demonstrate that the combined treatment with lenvatinib and cisplatin enhances the response of OSCC cells under hypoxic conditions. Additionally, it aims to mitigate the negative impact of hypoxia on cisplatin's therapeutic effectiveness and increase the sensitivity of OSCC cells to cisplatin. Citation Format: Ying-Tzu Chen, Yan-Ting Tsai, Fei-Ting Hsu, Hsi-Feng Tu. Evaluate the potential sensitization effect and underlying mechanism of lenvatinib on cisplatin resistance oral squamous cell carcinoma [abstract]. In: Proceedings of the American Association for Cancer Research Annual Meeting 2024; Part 1 (Regular Abstracts); 2024 Apr 5-10; San Diego, CA. Philadelphia (PA): AACR; Cancer Res 2024;84(6_Suppl):Abstract nr 4736.

Proteasome Inhibitor Lactacystin Enhances Cisplatin Cytotoxicity by Increasing Endoplasmic Reticulum Stress-Associated Apoptosis in HeLa Cells

Cisplatin Induces Apoptosis of Hepatocellular Carcinoma LM3 Cells Via Down-Regulation of XIAP.

Nuclear proteome analysis of cisplatin-treated HeLa cells

Trichostatin A Promotes Cytotoxicity of Cisplatin, as Evidenced by Enhanced Apoptosis/Cell Death Markers

Er Stress and Autophagy Are Involved in the Apoptosis Induced by Cisplatin in Human Lung Cancer Cells

Lysophosphatidic Acid Inhibits Apoptosis Induced by Cisplatin in Cervical Cancer Cells

Calcium efflux from the endoplasmic reticulum regulates cisplatin-induced apoptosis in human cervical cancer HeLa cells

The Effect of Lipocisplatin on Cisplatin Efficacy and Nephrotoxicity in Malignant Breast Cancer Treatment

Z-Ligustilide Combined with Cisplatin Reduces PLPP1-Mediated Phospholipid Synthesis to Impair Cisplatin Resistance in Lung Cancer

Inhibition of Autophagy Enhances Cisplatin Cytotoxicity Through Endoplasmic Reticulum Stress in Human Cervical Cancer Cells

Combination of cyanidin-3-O-glucoside and cisplatin induces oxidative stress and apoptosis in HeLa cells by reducing activity of endogenous antioxidants, increasing bax/bcl-2 mRNA expression ratio, and downregulating Nrf2 expression

Effect of Cisplatin Alone or Combined with Monoclonal Anti-Programmed Death Ligand-1 Anti-Body on Lung Adenocarcinoma Cell Line SPCA-1 and T Lymphocytes

Abstract 4736: Evaluate the potential sensitization effect and underlying mechanism of lenvatinib on cisplatin resistance oral squamous cell carcinoma

A New Strategy of Promoting Cisplatin Chemotherapeutic Efficiency by Targeting Endoplasmic Reticulum Stress.

Isoalantolactone Increases the Sensitivity of Prostate Cancer Cells to Cisplatin Treatment by Inducing Oxidative Stress

Dichloroacetate shifts the metabolism from glycolysis to glucose oxidation and exhibits synergistic growth inhibition with cisplatin in HeLa cells.

Enhancement of Cisplatin Induced Apoptosis by Suberoylanilide Hydroxamic Acid in Human Oral Squamous Cell Carcinoma Cell Lines

TAT‑fused IP3R‑derived Peptide Enhances Cisplatin Sensitivity of Ovarian Cancer Cells by Increasing ER Ca2+ Release

Synergistic anti-cancer action of salicylic acid and cisplatin on HeLa cells elucidated by network pharmacology and in vitro analysis

Icariside II enhances cisplatin-induced apoptosis by promoting endoplasmic reticulum stress signalling in non-small cell lung cancer cells.

Gallic acid induces apoptosis and enhances the anticancer effects of cisplatin in human small cell lung cancer H446 cell line via the ROS-dependent mitochondrial apoptotic pathway